Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Available-For-Sale Securities (Tables)

Cash, Cash Equivalents and Available-For-Sale Securities (Tables)

6 Months Ended

Jun. 30, 2013

Cash, Cash Equivalents and Available-For-Sale Securities

Schedule of cash, cash equivalents and available-for-sale securities

Cash, cash equivalents and available-for-sale securities consisted of the following (in thousands):

	June 30,		December 31,
	2013		2012
Checking account	$	281	$	251
Money market funds	7,688		23,936
Government-sponsored enterprise securities	92,470		77,047
Corporate bonds and commercial paper	151,202		197,007
	$	251,641	$	298,241
Reported as:
Cash and cash equivalents	$	21,868	$	33,484
Available-for-sale securities	229,773		264,757
	$	251,641	$	298,241

Schedule of cash equivalents and available-for-sale securities including the securities with unrealized gains and losses

Cash equivalents and available-for-sale securities include the following securities with unrealized gains and losses (in thousands):

			Gross		Gross
	Amortized		Unrealized		Unrealized
June 30, 2013	Cost		Gains		Losses			Fair Value
Government-sponsored enterprise securities	$	92,459	$	25	$	(14	)	$	92,470
Corporate bonds and commercial paper	151,196		54		(48		)	151,202
Total	$	243,655	$	79	$	(62	)	$	243,672

			Gross		Gross
	Amortized		Unrealized		Unrealized
December 31, 2012	Cost		Gains		Losses			Fair Value
Government-sponsored enterprise securities	$	77,041	$	37	$	(31	)	$	77,047
Corporate bonds and commercial paper	196,931		98		(22		)	197,007
Total	$	273,972	$	135	$	(53	)	$	274,054

Schedule of contractual maturities of cash equivalents and available-for-sale securities

As of June 30, 2013, the contractual maturities of our cash equivalents and available-for-sale securities were (in thousands):

	Years to Maturity
			After One Year
	Within One		Through
	Year		Two Years
Government-sponsored enterprise securities	$	56,069	$	36,401
Corporate bonds and commercial paper	149,647		1,555
	$	205,716	$	37,956

Schedule of fair value and gross unrealized losses of the entity's investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):

			Unrealized
June 30, 2013	Fair Value		Losses
Government-sponsored enterprise securities	$	31,495	$	(14	)
Corporate bonds and commercial paper	67,105		(48		)
Total	$	98,600	$	(62	)